Fluspirilene

Fluspirilene

File:Fluspirilene.svg
Clinical data
Routes of administration	IM
ATC code	N05AG01 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
IUPAC name 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
CAS Number	1841-19-6
PubChem CID	3396
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C29H31F2N3O
Molar mass	475.573 g/mol

Fluspirilene is a diphenylbutylpiperidine antipsychotic drug, used for the treatment of schizophrenia. It is administered intramuscularly.

It was discovered at Janssen Pharmaceutica in 1963.

References

• van Epen JH, Experience with fluspirilene (R 6218), a long-acting neuroleptic, Psychiatr Neurol Neurochir. 1970 Jul-Aug;73(4):277-84.
• Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Verbruggen FJ, van Nueten JM, Marsboom RH, Herin VV, Schaper WK., The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug, Arzneimittelforschung. 1970 Nov;20(11):1689-98.

Template:Drug-stub